JCPenney Gets $2.25...
Health Care: Drugs
Akorn Inc. (AKRX: NASDAQ)
$14.59 0.04 | 0.27%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 40.78M | 83.96M | 41.62M | 1.62M |
| Receivables | 51.02M | 25.31M | 11.27M | 10.06M |
| Inventories | 52.50M | 35.46M | 18.92M | 13.17M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 158.71M | 155.95M | 73.61M | 26.07M |
| Property, Plant & Equipment, Gross | 128.31M | 87.45M | 72.39M | 67.64M |
| Accumulated Depreciation & Depletion | 47.64M | 43.06M | 39.66M | 36.17M |
| Property, Plant & Equipment, Net | 80.68M | 44.39M | 32.73M | 31.47M |
| Intangibles | 80.38M | 80.84M | 3.12M | 4.62M |
| Other Non-Current Assets | 16.70M | 14.11M | 1.65M | 6.60M |
| Total Non-Current Assets | 210.86M | 151.20M | 37.50M | 42.69M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 369.56M | 307.14M | 111.12M | 68.76M |
| Accounts Payable | 21.78M | 17.87M | 4.89M | 3.29M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 3.00M |
| Other Current Liabilities | 0.00 | 0.00 | 10.18M | 10.56M |
| Total Current Liabilities | 43.29M | 28.29M | 21.94M | 21.67M |
| Long Term Debt | 120.75M | 114.65M | 0.00 | 5.85M |
| Deferred Income Taxes | 1.99M | 3.74M | 0.00 | 0.00 |
| Other Non-Current Liabilities | 1.30M | 2.26M | 1.30M | 1.30M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 125.19M | 120.65M | 2.42M | 8.46M |
| Total Liabilities | 168.48M | 148.94M | 24.36M | 30.12M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 201.08M | 158.21M | 86.75M | 38.64M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 226.04M | 212.64M | 182.47M | 174.03M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -37.00M | -72.37M | -115.39M | -137.21M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 12.04M | 17.95M | 19.67M | 1.82M |
| Total Capitalization | 321.83M | 272.86M | 86.75M | 44.49M |
| Total Equity | 201.08M | 158.21M | 86.75M | 38.64M |
| Total Liabilities & Stock Equity | 369.56M | 307.14M | 111.12M | 68.76M |
| Total Common Shares Outstanding | 95.84M | 94.94M | 93.98M | 90.39M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 95.19M | 94.55M | 92.80M | 90.25M |
| Diluted Weighted Shares Outstanding | 110.51M | 103.91M | 99.25M | 90.25M |
| Number of Employees | 976 | 553 | 410 | 329 |
| Number of Part-Time Employees | 8 | 11 | 0 | 0 |
Portfolios with AKRX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 18
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 16
- UserGFNN Stockdiagnostics 11
- Userpharmacy
- UserGFNN Stockdiagnostics 4
- UserGFNN Stockdiagnostics
- ContributorStocks At New 52-Week Highs...
Latest AKRX Headlines from TheStreet
- AKRX Crosses Below Key Moving Average Level 05.07.13 | 11:05 am
- 5 Stock Insiders are Gobbling Up 12.19.12 | 12:12 pm
- Akorn CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 12:08 pm
- Cramer's 'Mad Money" Recap: Curb Your Enthusiasm 07.11.12 | 07:07 pm
- 7 High-Volume Stocks With Relative Strength 07.09.12 | 02:07 pm
- Akorn Stock Hits New 52-Week High (AKRX) 06.19.12 | 11:06 am
- Akorn Reaches New 52-Week High (AKRX) 06.08.12 | 03:06 pm
- Akorn Inc. (AKRX): Today's Featured Drugs Loser 06.06.12 | 06:06 pm
- Akorn Inc. (AKRX): Today's Featured Drugs Loser 06.06.12 | 05:06 pm
- Akorn Stock Hits New 52-Week High (AKRX) 05.30.12 | 02:05 pm
Press Releases for AKRX
- Akorn Reports 2012 Fourth Quarter And Year-End Financial Results - Business Wire 02.26.13 | 07:02 am
- Akorn Provides Financial Guidance For 2013 - Business Wire 01.17.13 | 02:01 pm
- Akorn Reports Third Quarter 2012 Financial Results - Business Wire 11.06.12 | 06:11 am
- Akorn Announces The Approval And Launch Of Generic Prometrium® - Business Wire 10.24.12 | 06:10 am
- Akorn’s Chairman Adopts 10b5-1 Trading Plan - Business Wire 09.24.12 | 11:09 am
- Akorn Announces New Management Appointments - Business Wire 08.07.12 | 07:08 am
- Akorn Reports Preliminary Second Quarter 2012 Financial Results - Business Wire 08.07.12 | 07:08 am
- Akorn To File Amended Unaudited Financial Statements For The Quarter Ended March 31, 2012 - Business Wire 08.07.12 | 06:08 am
- Akorn Reports Record First Quarter 2012 Financial Results - Business Wire 05.08.12 | 06:05 am
- Akorn Announces The Approval And Launch Of Generic Vancocin® - Business Wire 04.10.12 | 06:04 am
Partner Headlines for AKRX
- Akorn Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 05.07.13 | 10:05 am
- Akorn Earnings: Your Sneak Peek to the Big Announcement - Wall St. Cheat Sheet 05.06.13 | 06:05 am
- 5 Big Buys By Oak Ridge Investments - Seeking Alpha 11.10.12 | 01:11 am
- Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL - NASDAQ 09.24.12 | 02:09 pm
- Healthcare Business Review: Savient's Favorable RULING, Forest Gets FDA OKAY - Wall St. Cheat Sheet 07.24.12 | 08:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.09.12 | 09:07 am
- Las Vegas Sands a BUY and 4 Must-See Expert Insights - Wall St. Cheat Sheet 07.09.12 | 04:07 am
- Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases - Zacks 02.08.12 | 09:02 am
- Akorn, Inc. - Momentum - Zacks 02.08.12 | 01:02 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.20.12 | 09:01 am
